The Microrna Biomarkers Market is estimated at US$0.8 billion in 2026 and is projected to grow at a CAGR of 2.8% to reach US$1 billion by 2034.
Core demand comes from oncology diagnostics, cardiovascular assessment, neurology research, companion diagnostics, and translational biomarker studies, where users value sensitivity, disease relevance, and translational utility. Suppliers are refining assay design, normalization methods, and interpretation workflows to match changing expectations across research, diagnostic development, and precision medicine programs.
This product will be delivered within 1-3 business days.
Market Overview
The Microrna Biomarkers Market covers biomarker discovery, assay development, and diagnostic applications based on micro ribonucleic acid signatures associated with disease states and biological processes.Core demand comes from oncology diagnostics, cardiovascular assessment, neurology research, companion diagnostics, and translational biomarker studies, where users value sensitivity, disease relevance, and translational utility. Suppliers are refining assay design, normalization methods, and interpretation workflows to match changing expectations across research, diagnostic development, and precision medicine programs.
Market Segmentation
By Technology
- Next-Generation Sequencing (NGS)
- Digital & Droplet Digital PCR (ddPCR)
- Microarray
- Others
By Application
- Cancer
- Cardiovascular Diseases
- Neurological Disorders
- Autoimmune Disorders
- Infectious Diseases
By Product & Service
- Kits and Reagents
- Instruments and Platforms
- Software and Bioinformatics Tools
- Services
By End User
- Pharmaceutical and Biotechnology Companies
- Academic and Research Institutes
- Hospitals and Clinics
Geographic Coverage
- North America - Market data and outlook to 2034
- United States
- Canada
- Mexico
- Europe - Market data and outlook to 2034
- Germany
- United Kingdom
- France
- Italy
- Spain
- Netherlands
- Switzerland
- Poland
- Sweden
- Russia
- Asia-Pacific - Market data and outlook to 2034
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Malaysia
- Vietnam
- Middle East and Africa - Market data and outlook to 2034
- Saudi Arabia
- South Africa
- Iran
- UAE
- Egypt
- South and Central America - Market data and outlook to 2034
- Brazil
- Argentina
- Chile
- Peru
Report Delivery and Support
- Updated PDF report and an MS Excel workbook containing market tables and figures.
- 7-day post-sale analyst support for clarifications and in-scope supplementary data.
- Complimentary report update covering the latest available data and relevant market developments.
This product will be delivered within 1-3 business days.
Table of Contents
1. Contents and Report Guide
2. Global Microrna Biomarkers Market Overview
3. Microrna Biomarkers Market Dynamics
4. Microrna Biomarkers Market Strategic Analysis
5. Global Microrna Biomarkers Market Size, Share and Forecast, 2025-2034
6. North America Microrna Biomarkers Market Outlook to 2034
7. Europe Microrna Biomarkers Market Outlook to 2034
8. Asia-Pacific Microrna Biomarkers Market Outlook to 2034
9. Middle East and Africa Microrna Biomarkers Market Outlook to 2034
10. South and Central America Microrna Biomarkers Market Outlook to 2034
11. Microrna Biomarkers Market Competitive Landscape
12. Appendix
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 160 |
| Published | October 2026 |
| Forecast Period | 2026 - 2034 |
| Estimated Market Value ( USD | $ 0.8 Billion |
| Forecasted Market Value ( USD | $ 1 Billion |
| Compound Annual Growth Rate | 2.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 20 |
